About This Role As the Global S&OP & Long-Term Planning Lead, you will play a pivotal role in shaping how Biogen connects commercial strategy, supply chain planning, financial priorities, and long-term business growth. As part of
What its about We are one of the largest global private markets investment managers, serving over 800 institutional investors worldwide. We have USD 185 billion in assets under management and around 2,000 professionals across 24 offices
HR Project Manager Department: Group HR – Baar We are seeking a highly motivated Project Manager to join our Group Human Resources team. This role is ideal for someone who can think strategically to scope and
Company Description Sika is a specialty chemicals company with a globally leading position in the development and production of systems and products for bonding, sealing, damping, reinforcing, and protection in the building sector and industrial manufacturing.
Global Marketing Director, Oncology Location: Zug - Switzerland, GSK HQ - London or Upper Providence - USA GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion
Patient Affairs Lead, Oncology (Switzerland) – Swiss Marketing Company Are you ready to elevate the patient voice in oncology and turn real-world insights into decisions that improve education, access and standards of care across Switzerland? As
About This Role: As the Dravet CMI Lead within the Global CE&O team, you will spearhead the creation and synthesis of customer and market insights (CMI) for Dravet PDC (Product Development and Commercialization). Your role is
At Chain IQ, your ideas move fast. Chain IQ is a global AI‑driven procurement service partner headquartered in Baar, Switzerland, with operations across 16 offices worldwide. We are looking for a Senior Consultant in Procurement Operations
Global Marketing Director, Oncology Location: Zug - Switzerland, GSK HQ - London or Upper Providence - USA GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion